Special Issue "Emerging Drug Discovery Approaches against Infectious Diseases"
Deadline for manuscript submissions: closed (8 November 2017) | Viewed by 87938
Interests: multitarget anti-Alzheimer agents; hybrid compounds; cholinesterase inhibitors; amyloid anti-aggregating compounds; BACE-1 inhibitors; antiprotozoan compounds
Special Issues, Collections and Topics in MDPI journals
Special Issue in Molecules: Multicomponent Reaction-Based Synthesis of Bioactive Molecules
Special Issue in Molecules: Present and Future of Medicinal Chemistry Research: A Young Researchers’ Perspective
Special Issue in Molecules: Molecules against Alzheimer II
Special Issue in Molecules: Facing Novel Challenges in Drug Discovery
Topical Collection in Molecules: Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes
Special Issue in Molecules: Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes 2020
Special Issue in Molecules: Feature Papers to Celebrate Molecules Reaches 20,000 Articles Milestone
Special Issue in Molecules: 25th Anniversary of Molecules—Recent Advances in Medicinal Chemistry
Special Issue in Molecules: Molecules Medicinal Chemistry Reviews
Special Issue in Molecules: Featured Papers in Medicinal Chemistry
Special Issue in Molecules: Molecules in 2022
Special Issue in Molecules: Shaping Medicinal Chemistry for the New Decade
Special Issue in Molecules: Exclusive Papers from the Editorial Board Members (EBMs) of the Section “Medicinal Chemistry” of Molecules
Special Issue in Molecules: Featured Papers in Medicinal Chemistry II
Interests: antiparasitic and antibacterial drug discovery; antimalarial agents; antituberculosis agents; antischistosomiasis agents; drug repositioning; efflux pump inhibitors
This Special Issue is related to the 1st Molecules Medicinal Chemistry Symposium (MMCS 2017), which will be held on 8 September, 2017, at the Faculty of Pharmacy and Food Sciences of the University of Barcelona.
Infectious diseases inflict tremendous human suffering, especially in the most disfavored countries, where they cause a huge economic burden that hampers their way out of poverty. Efficacy and safety issues, as well as the rapid emergence of drug resistance in human pathogens, undermine the clinical usefulness of many currently available drugs, thereby making the development of novel anti-infective drugs a dire need and anti-infective drug discovery a hot research front.
Participants of the symposium, as well as all researchers working in the field, are cordially invited to contribute original research papers or reviews to this Special Issue of Molecules, which report on the design, synthesis, and evaluation of novel drug candidates against bacterial, protozoan, viral, and fungal infections, the identification of novel biological targets or therapeutic approaches, or studies about resistance mechanisms and strategies to circumvent them.
Prof. Dr. Diego Muñoz-Torrero
Prof. Dr. Kelly Chibale
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Structure-based drug design
- Ligand-based drug design
- Drug synthesis
- Target-based assays
- Phenotypic screening
- Target validation
- Drug resistance
- Resistance mechanisms